IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 5475 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   [PDF Not available] *
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References

 Article Access Statistics
    Viewed3623    
    Printed49    
    Emailed2    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal

 


 
LETTER TO EDITOR
Year : 2000  |  Volume : 66  |  Issue : 1  |  Page : 49-50

The pulse rate of pulse therapy




Correspondence Address:
Anurag Tiwari


Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 20877026

Rights and PermissionsRights and Permissions



How to cite this article:
Tiwari A, Srinivas C R, Ramalingam S. The pulse rate of pulse therapy. Indian J Dermatol Venereol Leprol 2000;66:49-50

How to cite this URL:
Tiwari A, Srinivas C R, Ramalingam S. The pulse rate of pulse therapy. Indian J Dermatol Venereol Leprol [serial online] 2000 [cited 2019 Jun 24];66:49-50. Available from: http://www.ijdvl.com/text.asp?2000/66/1/49/4868


To the Editor

Dexamethasone pulse therapy alone or in combination with cyclophosphamide is used for the treatment of pemphigus, systemic sclerosis, SLE and others. The minor side effects include transient symptoms of hypotension or hypertension,[1]metallic taste within hours after receiving first infusion and pitting oedema of ankles.[2] Other side effects reported include acute arthralgia, [3],[4],[5]a transient syndrome of joint pain, swelling or both. Baethge et al reported 4 patients who developed hiccups persisting longer than 24 hours after treatment with high-dose intravenous methylprednisolone.[6] Hiccups persisting longer than 48 hours are considered intractable.[7]

Several cases of sudden death after taking dexamethasone or methylprednisolone have been reported. [8],[9]Some, but not all, were associated with rapid infusions or pre-existing heart disease.[10] Studies in animals have suggested that intravenous steroids can be arrhythmogenic and speed of administration has been suggested as an important factor.[11] Intravenous bolus of steroids administered over a relatively short period (10 to 20 min) is associated with fatal events.[12] Concomitant use of furosemide also increases the incidence of death.[12] Rapid infusion of steroids associated with concomitant use of furosemide may lead to sudden potassium shifts and result in decreased total peripheral resistance and/ or cardiac arrhythmias.[3]lt has been suggested that increasing the infusion time to at least 30 minutes might prevent these events.[13]

To avoid these complications it is avocated that dexamethasone 100mg be added to 500ml of 5% dextrose and infused over three hours. More often than not we found the nursing staff and prescribing doctor are unaware of the drops per minute required to complete the therapy over the desired time and how much steroid is administered per ml of dextrose water. We have calculated the number of drops/ min. required to administer the medication for various times which are as follows. The algorithm has been arrived by taking into consideration that 15 drops of a fluid amount to Iml. Thus when giving 500ml/ in 3 hours (180min) we have to infuse 500 / 180 = 2.7 ml/min.

Since iml = 15 drops

2.7ml = 40.5 drops

Thus,

500m1 over 3 hours = 2.7m1 / min =41 drops/min Similarly, 500m1 over 31/2 hours = 2.3ml/min =35 drops/min

Also in 500m1 of solution we add 100mg of dexam­ethasone thus each ml contains 100/500 = 0.2mg.

We submit this write up not as on original finding but to reinforce what is already established.



 
  References Top

1.Liebling MR, Leib E, Me laughlin K, et al. Pulse methylprednisolone in rheumatoid arthritis. Ann Int. Med 1981;94:21-26.  Back to cited text no. 1    
2.Fan PT, Yu DTY, Clenents PI, et al. Effects of corticosteroids on human immune response: Comparison of one and three daily 1 gm intravenous pulses of methyl prednisolone. 3 Lab Clin Invest, 1973; 53:2629 -2640.  Back to cited text no. 2    
3.Newmark KJ et al: Acute arthralgia following high dose of intravenous methylprednisolone therapy. Lancet 1974; ii: 229.  Back to cited text no. 3    
4.Bailey BR, Armour P. Acute arthralgia after high dose intravenous methylprednisolone. Lancet, 1974;ii:1014.  Back to cited text no. 4    
5.Bennet WM, Strong D: Arthralgia after high dose steroids. Lancet 1:332,1975;1:332.  Back to cited text no. 5    
6.Baethge BA, Lidsky MD. Intractable hiccups associated with high dose intravenous methylprednisolone therapy. Ann Intern Med. 1986;104:58-59.  Back to cited text no. 6    
7.Souadijan 3V, Cain JC. Intractable hiccups-etiological factors in 220 cases. Postgrad Med J. 43:72-77, 1968; 43;72-77.  Back to cited text no. 7    
8.Schmidt GB, Meier MA, Sadave MS. Sudden appearance of cardiac arrhythmias after dexamethasone. JAMA,221:1404,1972;221: 142­1404.  Back to cited text no. 8    
9.Bocanegra TS, Castaneda Mo, Espinoza LR, et al. Sudden death after methylprednisolone pulse therapy. Ann Intern Med, 1981; 95:122.  Back to cited text no. 9    
10.Gardiner PVG, Griffiths ID: Sudden death after treatment with pulsed methylprednisolone. Br Med J, 1990 ; 300: 125.  Back to cited text no. 10    
11.Barry M. 'The use of high dose pulse methylprednisolone in rheumatoid arthritis. Arch Intern Med 1985;145:1483-1484.  Back to cited text no. 11    
12.Stubbs SS, Morrell RN. Intravenous methylprednisolone sodium succinate: adverse reactions reported in association with immunosuppressive therapy. Transplant Proc.1973;5:1145-1146.  Back to cited text no. 12    
13.Olds JW, Reed WP, Eberle B, et al. Corticosteroids, serum and phagocytosis: in vitro and vivo studies. Infect Immum 1974 ; 9 524-529.  Back to cited text no. 13    




 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow